Confirmed
Two or more controlled phase 3 trials met their main goal.
Interferon beta: reduce relapses and new lesions in early MS (CIS or RIS)
early MS (CIS or RIS) · Interferon beta
Two or more controlled phase 3 trials met their main goal, or one did and a medicine of this approach is approved for this use.
- Trials
- 5
- Running now
- 0
- Controlled phase 2/3 trials
- 2
- People in controlled trials
- 919
Deciding trials (phase 3): 2 met, 0 did not.
Other linked trials: 3
Dose comparisons, trials against another medicine, add-on trials, phase 1 and uncontrolled studies. They are listed below but do not set the status.
Trials
Phase 3 · 2008 · Placebo-controlled · MSFT-NCT00813709
Phase 3 · 2006 · Placebo-controlled · MSFT-NCT00404352
Other linked trials: 3
These linked trials do not set the status.
- EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple SclerosisNo result found
Phase 4 · 2004 · Not randomised
- CIS-ONNo result found
Phase 3 · 2005 · Not randomised
Phase 3 · 2002 · Not randomised
The deciding phase and counts come from the Trial Bank’s fixed rules.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- 2026-10-27First listed as Confirmed
Related hypotheses
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error